MANUFACTURING LAB
🇬🇧
In English
In English
Practice Known Questions
Stay up to date with your due questions
Complete 5 questions to enable practice
Exams
Exam: Test your skills
Test your skills in exam mode
Learn New Questions
Manual Mode [BETA]
Select your own question and answer types
Specific modes
Learn with flashcards
Complete the sentence
Listening & SpellingSpelling: Type what you hear
multiple choiceMultiple choice mode
SpeakingAnswer with voice
Speaking & ListeningPractice pronunciation
TypingTyping only mode
MANUFACTURING LAB - Leaderboard
MANUFACTURING LAB - Details
Levels:
Questions:
142 questions
🇬🇧 | 🇬🇧 |
Include genetically engineered microorganisms, cell cultures, as well as endoparasites, whether pathogenic or not. | Microbiological Agents |
Contaminations of a starting, intermediate product or finished product. | Cross Contamination |
The date indicating the start of processing of every batch. | Date of Manufacture |
Written recording of all procedures, instructions and processes involved in the manufacture of drug products. | Documentation |
Are jointly responsible to establish for the quality, strength, purity and efficacy of the finished products. | 1 production manager and the 2 quality assurance manager |
Training shall be conducted by qualified individuals. Special attention shall be given to training of personnel working in __ | Sterile and clean areas or with highly potent, toxic or sensitizing materials. |
In determining the design and lay-out of premises, consideration should be paid to: | 1 the compatibility of other manufacturing operations that may be carried out in the same or adjacent premises 2 allow the production to take place in areas connected in a logical order according to the sequence of the operations and to the requisite cleanliness levels 3 the adequacy of the working space, which shall allow orderly and logical placement of equipment and materials to suit the operation, efficient flow of work, effective communication and supervision to avoid crowding and disorder 4 avoid the use of production areas as a general traffic for personnel or materials or for storage other than the materials in process. |
The layout of rooms, corridors, and spaces shall provide for logical movements of materials and personnel with minimal traffic for operations to be carried out in defined areas and to avoid cross contamination. The design and layout of premises shall fulfill the following requirements: | 1 the risk of mix-up between different drugs or their components, the possibility of cross-contamination by other drugs or substances and the risk of omission of any production step shall be prevented 2 penicillins shall be produced only in separate buildings, with separate air handling facilities dedicated to these products using dedicated equipment, including dedicated packaging lines. 3 cephalosporins shall be produced in separate buildings, with separate air handling facilities dedicated to these products using dedicated equipment, including dedicated packaging lines 4 cross contamination of products should be prevented |
Cross contamination of products by live biologicals, or by drug products, such as certain steroids or cytotoxic agents which in trace amounts may produce physiological effects should be prevented by the following methods: | 1 carrying out production operations in separate buildings or adequately isolating the operations by total enclosure 2 controlling airborne contaminants by the use of an appropriate air pressure differential in processing areas and adequate exhaust systems and filters, together with control of recirculated air 3 the setting and shielding of production equipment, and wherever possible, the use of equipment solely for one type of drug/product; 4 containment of contaminant-transfer by means of airlocks, clothing change and decontamination of containers and other articles prior to their removal from the isolated area 5 separate cleaning area for contaminated clothing 6 periodic testing of the environment around the production areas for the presence of the therapeutic substance being processed and 7 validation of cleaning procedures. |
Separate space for: | 1 Cleaning mobile equipment 2 Storage of cleaning materials |
Defined areas for the following operations are required: | 1 gowning/change rooms for all personnel 2 receiving of starting materials 3 incoming goods quarantine 4 sampling room for sampling of deliveries of starting materials 5 storage for approved materials (chemical & packaging) 6 storage of reject materials 7 laboratories 8 weighing / dispensing of materials 9 processing operations 10 equipment washing 11 storage of cleaned, idle/non-functional equipment 12 major repair and maintenance activities 13 storage of cleaning tools and supplies 14 staging/storage of bulk products 15 packaging / labeling operations (+5 MORE) |
Storage areas shall be of adequate space, provided with suitable lighting, arranged and equipped to allow dry, clean and orderly placement of stored materials and products. : | 1 Special and secured areas shall be available for storage of flammable and explosive substances, highly toxic substances, narcotics and other dangerous drugs. 2 Storage areas shall be laid-out to permit effective and orderly segregation of the various categories of materials stored to allow FIFO system. 3 Segregated storage shall be provided for rejected, recalled or returned goods. 4 Storage arrangements shall permit separation of different labels, as well as other printed materials to avoid mix-up. 5 Materials require special storage conditions such as temperature and/or humidity controls. These conditions should be monitored and records of the monitoring retained. |
A complete set of activities to produce drugs from start to finish to produce a product | Manufacturing |
Manufacturing vs Compounding | Manufacturing is a LARGE SCALE production Compounding is a SMALL SCALE production Both produces drugs |
Any organization involved in manufacturing, importing, packaging and distribution of drugs | Drug Establishment |
Included here are Branded or generic drugs | Proprietary/Generic Manufacture |
Included here are Medicinal products | Medicinal manufacture |
Included here are Animal drug products | Veterinary manufacture |
Sole owner of products. | Traders |
Hired manufacturing firm by traders – sole owner of products. | Toll / Contract Manufacturing |
Drug Establishments: | 1 Drug manufacture 2 Drug importer 3 Drug exporter 4 Drug traders 5 Drug supplier 6 Drug distributor/wholesale time sd |
Local drugs transported internationally | Drug exporter |
Transports raw materials to local places. | Drug distributor/wholesale |
Departments of Drug Establishments | 1 Marketing Department 2 Research Department 3 Production Department 4 Quality Control Department: SARS 5 Engineering Department 6 Purchase Department 7 Medical Department |
Main role is PRODUCT POSITIONING (put products in consumers’ minds ) - Spying other company - Promotes products; Responsible of marketing products - Ads; conventions | Marketing Department |
- Main role: formulate, improve drug products - Facilities: library, pilot plant, animal house | Research Department |
Main roles: Manufacture and production Warehousing Acceptance of new materials | Production Department |
- Ensures public safety - Areas: Raw Materials QC, Intermediate Products QC, Finished Products QC - Sampling | Quality Control Department: SARS |
Role: Purchase; inventory | Purchase Department |
- Preclinical and clinical studies - Physical exams of employees - Treatment of employees - Make package inserts | Medical Department |
Drug Discovery Process | 1 New chemical entity -> 2 Preclinical studies -> 3 IND application -> 4 Clinical trials and Preclinical studies (continued) -> 5 NDA (New Drug Application) application -> 6 Post-marketing |
- Initial synthesized entity tested on animals - Study of the ADME | Preclinical Studies |
Start of approval for clinical trials | IND Application |
Phase 1 | - 20-100 healthy individuals - Test: Safety and dosage - Know how the treatment is given - Period: Months - 1 year |
Phase 2 | - 100-200 individuals with diseases - Test: Efficacy and side-effects – degree on how a drug can prevent or treat a disease - Know the route and dosage form of drug |
Phase 3 | - 1000+ individuals with the target disease - Test: Efficacy in a normal clinical condition - Know how to achieve better bioavailability |
Phase 4 | Post-marketing |
Final drug product without the packaging | Intermediate product |
Final drug product with the packaging | Finished product |
Current Good Manufacturing Practices for Drugs What Law? | (A.O. 43, Series of 1999) |
US FDA year | 1939 |
GMP year | 1956 |
BFAD year | 1974 |
1 Why is cGMP important? 2 What is the objective of cGMP? | 1) 1 To preserve the identity, strength, quality and purity of drugs. 2 To ensure the safety of personnel and patients. 2) 1 Prescribe standard guidelines in the manufacture of drug products. 2 Ensure that no person or establishment shall manufacture drugs under substandard conditions |
The design and construction of equipment shall fulfill the following requirements: | 1 the equipment surfaces coming in contact with any material shall not be reactive, additive or absorptive so as to alter safety, strength, identity, quality or purity of the drug beyond the established limits 2 equipment shall not adversely affect the product through leaking valves, lubricant drips, inappropriate repairs, maintenance, modifications or adaptations 3 materials required for specific operations, such as lubricants or coolants shall not come into contact with any in-process materials as to alter the strength, safety, identity, quality, or purity of raw material, intermediate, bulk or the finished product 4 equipment shall be easily and conveniently cleanable 5 all equipment designated for use with flammable substances or chemicals shall be explosion proof 6 equipment employed for weighing, measuring, testing and recording shall be regularly checked for accuracy and calibrated according to an appropriate program and procedure; records shall be maintained. 7 filters for liquid filtration used in the processing of products shall not release fibers or substances into such products. |
Installation and Location | 1 Equipment shall be suitably installed and located to eliminate cross-contamination 2 Equipment shall be located at a sufficient distance from other equipment to avoid congestion and to ensure that products do not become admixed or confused with one another. 3 All open mechanical belts and pulleys shall be equipped with safety guards. Water, steam and pressure or vacuum lines shall be installed so as to be easily accessible during all phases of operation. These shall be adequately labeled and marked to be easily recognized. 4 Each piece of equipment shall be clearly marked with an identifying number. 5 All pipes, tanks, jackets for steam or coolant shall be properly insulated to prevent possible injury and to minimize energy loss. 6 Piping to equipment designated for use with the pressurized steam shall be properly trapped and drained. 7 Heating, ventilation, air conditioning, potable water, purified water, distilled water, clean steam, compressed air, gases and other support systems must undergo validation. |
Contaminated with extraneous biological agents and therefore capable of spreading infection. | Infected ( Man or Animal) |